Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
BMC Psychiatry|July 18, 2018
Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trialJocelyn Fotso Soh, Susana G Torres-Platas, Serge Beaulieu, et al.Bipolar Disorders|July 5, 2020
A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium usersJocelyn Fotso Soh, Serge Beaulieu, Francesco Trepiccione, et al.Bipolar Disorders|December 15, 2012
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeurAnees Bahji, Elisa Brietzke, Noah C A Cooke, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive DisorderJoshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.Trials|November 14, 2020
The BEACON study: protocol for a cohort study as part of an evaluation of the effectiveness of smartphone-assisted problem-solving therapy in men who present with intentional self-harm to emergency departments in OntarioSimon Hatcher, Marnin Heisel, Oyedeji Ayonrinde, et al.Bipolar Disorders|September 7, 2019
Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task forceKamilla W Miskowiak, Ida Seeberg, Hanne L Kjaerstad, et al.The New England Journal of Medicine|August 2, 2023
Duration of Adjunctive Antidepressant Maintenance in Bipolar I DepressionLakshmi N Yatham, Shyam Sundar Arumugham, Muralidharan Kesavan, et al.Pageof 15